Sign in

CIK 0001800315

  • Non-accelerated filer
  • Smaller reporting company

Damora Therapeutics, Inc.

Sign in to watch
Ticker
DMRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
371957007
Phone
+1 781-281-9020
Business address
100 FIFTH AVENUE, SUITE 700, WALTHAM, MA, 02451
Former names
Galecto, Inc., Galecto Inc.
Open-market buys, last 90 days
$252,875
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$252,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Jarrett Jennifer +$253K Director, President and CEO 1 filing
Date Insider Transaction Shares Price Value Owned after
2025-06-18 Munshi Amit Director Grant or award · Stock Option (right to buy) +720 720
2024-06-20 Munshi Amit Director Grant or award · Stock Option (right to buy) +18,000 18,000
2023-06-14 Munshi Amit Director Grant or award · Stock Option (right to buy) +18,000 18,000
2022-06-14 Munshi Amit Director Grant or award · Stock Option (right to buy) +18,000 18,000
2020-11-02 Munshi Amit Director Conversion +4,793 4,793
2020-11-02 Munshi Amit Director Conversion · Series D Preferred Stock −1,844 0
2020-09-25 Munshi Amit Director Grant or award · Series D Preferred Stock +1,844 $27.11 $50K 1,844
2020-06-24 Munshi Amit Director Grant or award · Stock Option (right to buy) +109,187 109,187

Page 1 of 1 · 8 trades